The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117857369 11785736 9 F 20140130 20160822 20151130 20160825 EXP US-PFIZER INC-2015394289 PFIZER 61.00 YR M Y 78.91000 KG 20160825 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117857369 11785736 1 PS LYRICA PREGABALIN 1 Oral 75 MG, 1X/DAY EVENING Y 21446 75 MG CAPSULE, HARD QD
117857369 11785736 2 SS LYRICA PREGABALIN 1 Oral 75 MG, 2X/DAY Y 21446 75 MG CAPSULE, HARD BID
117857369 11785736 3 SS LYRICA PREGABALIN 1 Oral 75 MG, 2X/DAY (MORNING + EVENING) Y 3740527302 21446 75 MG CAPSULE, HARD BID
117857369 11785736 4 SS LYRICA PREGABALIN 1 75 MG, UNK Y M38210 21446 75 MG CAPSULE, HARD
117857369 11785736 5 C DIAZEPAM. DIAZEPAM 1 Oral 10 MG, 4X/DAY AS NEEDED 0 10 MG TABLET QID
117857369 11785736 6 C DIAZEPAM. DIAZEPAM 1 Oral 10 MG, 3X/DAY 0 10 MG TABLET TID
117857369 11785736 7 C DIAZEPAM. DIAZEPAM 1 0 TABLET
117857369 11785736 8 C CYCLOBENZAPRINE CYCLOBENZAPRINE 1 Oral 10 MG, 3X/DAY 0 10 MG TABLET TID
117857369 11785736 9 C ASPIRIN. ASPIRIN 1 Oral 81 MG, 1X/DAY (IN THE MORNING) 0 81 MG TABLET QD
117857369 11785736 10 C PRAVASTATIN. PRAVASTATIN 1 Oral 20 MG, 1X/DAY 0 20 MG TABLET QD
117857369 11785736 11 C TAMSULOSIN HCL TAMSULOSIN 1 Oral 0.4 MG, 1X/DAY (IN THE MORNING) 0 .4 MG CAPSULE QD
117857369 11785736 12 C MINOCYCLINE MINOCYCLINEMINOCYCLINE HYDROCHLORIDE 1 Oral 100 MG, 2X/DAY 0 100 MG CAPSULE BID
117857369 11785736 13 C MINOCYCLINE MINOCYCLINEMINOCYCLINE HYDROCHLORIDE 1 Oral 100 MG, 1X/DAY 0 100 MG CAPSULE QD
117857369 11785736 14 C BENAZEPRIL BENAZEPRIL HYDROCHLORIDE 1 Oral 40 MG, 1X/DAY 0 40 MG TABLET QD
117857369 11785736 15 C NAPROXEN SODIUM. NAPROXEN SODIUM 1 Oral 220 MG, 2X/DAY (ONCE IN MORNING ONCE IN THE AFTERNOON) 0 220 MG TABLET BID
117857369 11785736 16 C NAPROXEN SODIUM. NAPROXEN SODIUM 1 0 TABLET
117857369 11785736 17 C PROBIOTICS XL 2 1 DF, 2X/DAY (2 A DAY MORNING AND EVENING) 0 1 DF BID
117857369 11785736 18 C OMEGA XL DIETARY SUPPLEMENT 1 Oral 300 MG, 4X/DAY (300MG, UP TO 4 A DAY) 95-14-145A 0 300 MG CAPSULE, SOFT QID
117857369 11785736 19 C CIPROFLOXACIN HCL CIPROFLOXACIN HYDROCHLORIDE 1 750 MG, 2X/DAY 0 750 MG CAPSULE BID
117857369 11785736 20 C CIPROFLOXACIN HCL CIPROFLOXACIN HYDROCHLORIDE 1 Oral 100 MG, 2X/DAY 0 100 MG CAPSULE BID
117857369 11785736 21 C BENAZEPRIL HCL BENAZEPRIL HYDROCHLORIDE 1 Oral 40 MG, 1X/DAY 0 40 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117857369 11785736 1 Diabetic neuropathy
117857369 11785736 2 Paraesthesia
117857369 11785736 3 Neuropathy peripheral
117857369 11785736 5 Hypertension
117857369 11785736 6 Increased appetite
117857369 11785736 7 Hypertension
117857369 11785736 8 Arthritis
117857369 11785736 9 Cardiac disorder
117857369 11785736 11 Urinary tract infection
117857369 11785736 12 Infection
117857369 11785736 13 Urinary tract infection
117857369 11785736 14 Blood pressure abnormal
117857369 11785736 15 Gastric disorder
117857369 11785736 16 Abdominal discomfort
117857369 11785736 17 Abdominal discomfort
117857369 11785736 18 Inflammation
117857369 11785736 19 Infection
117857369 11785736 21 Blood pressure abnormal

Outcome of event

Event ID CASEID OUTC COD
117857369 11785736 OT
117857369 11785736 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
117857369 11785736 Arthritis
117857369 11785736 Back disorder
117857369 11785736 Burning feet syndrome
117857369 11785736 Dyspnoea
117857369 11785736 Dyspnoea exertional
117857369 11785736 Echocardiogram abnormal
117857369 11785736 Expired product administered
117857369 11785736 Gait disturbance
117857369 11785736 Limb discomfort
117857369 11785736 Neck injury
117857369 11785736 Palpitations
117857369 11785736 Peripheral swelling
117857369 11785736 Post procedural infection
117857369 11785736 Pulse abnormal
117857369 11785736 Urinary tract infection
117857369 11785736 Weight increased
117857369 11785736 Withdrawal syndrome

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117857369 11785736 1 201401 0
117857369 11785736 2 20151110 0
117857369 11785736 3 201604 0
117857369 11785736 11 2015 0
117857369 11785736 14 2006 0
117857369 11785736 17 201601 0
117857369 11785736 18 201601 0
117857369 11785736 20 201508 0